Compositions and methods for lowering intraocular pressure
AssigneeAllergan, Inc.
InventorChetan P. Pujara
Life of this patent
Estimating the term…
Abstract
Disclosed herein are compositions for lowering intraocular pressure (IOP) of an eye comprising a combination IOP-lowering agents bimatoprost, brimonidine, and timolol. Further disclosed are methods for reducing IOP in the eye of a subject.
Claims6
A method for lowering intraocular pressure in patients suffering from elevated intraocular pressure who do not have adequate intraocular pressure control with mono or dual combination therapy, the method comprising administering to a patient a composition consisting essentially of about 0.01% w/v bimatoprost, about 0.15% w/v brimonidine tartrate, about 0.68% w/v timolol maleate, sodium phosphate dibasic heptahydrate, citric acid monohydrate, sodium chloride, and sodium hydroxide in an aqueous carrier.
Dependencies are inferred from the claim text.